logo

EDIT

Editas Medicine·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
3.91 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy EDIT Now?
  • Based on a composite score of 3.91/10, we rate EDIT as a Netural. Our analysis breaks down into 4.30/10 for Fundamentals, 2.31/10 for Technicals, and 4.51/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is EDIT fundamentally strong?
What is the current technical signals for EDIT?
What is the market sentiment for EDIT?